相关实验视频
Updated: Jul 9, 2025

10:28
Body Composition and Metabolic Caging Analysis in High Fat Fed Mice
Published on: May 24, 2018
15.6K
葡萄糖类-1和化学素对肥胖发展的相反影响的进展
Qilong Zhang1, Jianping Ye2,3, Xiaohui Wang1
1School of Exercise and Health, Shanghai Frontiers Science Research Base of Exercise and Metabolic Health, Shanghai University of Sport, Shanghai 200438, China.
Experimental biology and medicine (Maywood, N.J.)
|December 7, 2023
概括
类似葡萄糖-1 (GLP-1) 和化学素在肥胖中具有相反的作用. 本综述探讨了它们的复杂相互作用,揭示了GLP-1疗法如何通过调节化学素水平和巨细胞两极分化来准肥胖症.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病研究研究
- 脂肪组织生物学 脂肪组织生物学
背景情况:
- 类似葡萄糖的-1 (GLP-1) 对于葡萄糖平衡至关重要,并促进体重减轻,但其抗肥胖机制尚未完全理解.
- 化学素是一种阿迪波金,与脂肪细胞分化和炎症有关,这是肥胖的主要特征.
- 了解GLP-1和化学素之间的相互作用对于开发新的肥胖治疗方法至关重要.
研究的目的:
- 综合审查GLP-1和化学素在肥胖和相关疾病中的作用.
- 为了阐明GLP-1和化学素之间的复杂,相互抑制的关系.
- 根据它们的相互作用,突出针对肥胖的潜在治疗策略.
主要方法:
- 关于GLP-1和肥胖中的化学素的既定和最新研究的文献综述.
- 分析它们对食物摄入,新陈代谢,巨细胞两极分化和脂肪组织热生成的影响.
- 对基于GLP-1的疗法影响化学素和相反的证据的审查.
主要成果:
- GLP-1促进抗炎M2巨细胞和脂肪组织热生成,而化学素具有相反的效果.
- GLP-1疗法在调节化学素表达方面显示出潜在的潜力.
- 化学素作为GLP-1 in vivo 的新型负调节剂.
结论:
- GLP-1和化学素表现出相互抑制的关系,显著影响肥胖.
- 针对这种相互作用为肥胖治疗提供了有希望的途径.
- 本综述为对肥胖的内分泌调节提供了新的见解.
相关概念视频
Glucagon-like Receptor Agonists
329
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
329
Regulation of Food Intake
244
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
244
Hormones Regulating Blood Glucose
3.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.4K
Hormonal Regulation
43.5K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
43.5K
GPCRs Regulate Adenylyl Cylase Activity
5.6K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.6K
Dipeptidyl Peptidase 4 Inhibitors
190
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
190

